Justin D. Gover

Insider Reports History

Location
Sovereign House, Vision Park, Histon, Cambridge, United Kingdom
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Justin D. Gover:

Stock Role Class Num Shares Value Price $ Report Date Ownership
COMPASS Pathways plc Director Share Option (Right to Buy) 52K Jul 29, 2025 Direct
Xenon Pharmaceuticals Inc. Director Share Option (Right to Buy) 17K Jun 5, 2025 Direct
Design Therapeutics, Inc. Director Stock option (right to buy) 15.8K Sep 9, 2025 Direct
Xenon Pharmaceuticals Inc. Director Restricted Share Units 2.65K Jun 5, 2025 Direct
GW PHARMACEUTICALS PLC Chief Executive Officer, Director Ordinary Shares 0 May 5, 2021 By Justin D. Gover 2020 Irrevocable Trust dated December 14, 2020
GW PHARMACEUTICALS PLC Chief Executive Officer, Director Ordinary Shares 0 May 5, 2021 By the Gover Family Investment LLP
GW PHARMACEUTICALS PLC Chief Executive Officer, Director Ordinary Shares 0 May 5, 2021 Direct
GW PHARMACEUTICALS PLC Chief Executive Officer, Director Share Options 0 May 5, 2021 Direct

Insider Reports Filed by Justin D. Gover

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DSGN Design Therapeutics, Inc. Sep 9, 2025 2 $0 4 Sep 10, 2025 Director
DSGN Design Therapeutics, Inc. Sep 9, 2025 0 $0 3 Sep 10, 2025 Director
CMPS COMPASS Pathways plc Jul 29, 2025 1 $0 4 Jul 30, 2025 Director
CMPS COMPASS Pathways plc Jul 29, 2025 0 $0 3 Jul 30, 2025 Director
XENE Xenon Pharmaceuticals Inc. Jun 5, 2025 2 $0 4 Jun 6, 2025 Director
XENE Xenon Pharmaceuticals Inc. Jun 5, 2024 1 $0 4 Jun 5, 2024 Director
XENE Xenon Pharmaceuticals Inc. Aug 10, 2023 1 $0 4 Aug 10, 2023 Director
XENE Xenon Pharmaceuticals Inc. Aug 8, 2023 0 $0 3 Aug 10, 2023 Director
GWPH GW PHARMACEUTICALS PLC May 5, 2021 19 $0 4 May 7, 2021 Chief Executive Officer, Director